In contrast, AFP at a cut-off of 11.2 μg/L showed slightly higher specificity (65.5%) with a similar sensitivity (82.9%), suggesting that combining both biomarkers may improve diagnostic accuracy and reduce false positives in HBV related HCC surveillance. Here, AFP is linked to hepatocellular carcinoma.